-The Hindustan Times   In what can be a boost for the Make in India slogan the industry and lab are entering into new areas of partnership-latest being transfer of technology from a CSIR lab to make multi nutritional health capsule from tea extracts. CSIR-Institute of Himalayan Bioresource Technology, Palampur in Himachal Pradesh has developed technology for extraction of catechins using water and green solvents without using any hazardous chemicals. The technology...

-Tehelka The new and improved Bill to prevent atrocities against Dalits runs the risk of being put in the cold storage A crime against Dalits happens every 18 minutes - three women raped every day, 13 murdered every week, 27 atrocities every day, six kidnapped every week and so on. This is the data compiled by the National Campaign on Dalit Human Rights, an NGO, which paints a grim picture of Indian...

-The Indian Express Moves to dilute labour-material ratio in MGNREGA and focus exclusively on select backward blocks will adversely impact rural poor. Before the general elections, free-market fundamentalists had lobbied fiercely to reshape so-called wasteful social-sector expenditures. Primary among their targets was the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), which, according to them, should become an unconditional cash transfer scheme. Post-elections, the late Gopinath Munde's espousal of the MGNREGA went...

-Down to Earth Sivasankaran's land grabbing spree has threatened millions of livelihoods, says report Indian origin businessman Chinnakannan Sivasankaran has engaged in aggressive land grabbing of more than half a million hectares across Africa, Asia and South America, putting millions of livelihoods at risk. This was revealed in a detailed report released by Barcelona-based non-profit GRAIN on Tuesday. The report says Sivasankaran diverted 0.56 million hectares of food-producing land to production of palm...

-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...